Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jan, 25 2026
Dec, 20 2025
Oct, 10 2025
Aug, 26 2025
Sep, 26 2025